About ProSci
ProSci is a company based in San Diego (United States) founded in 1998 was acquired by Genesee Scientific in February 2023. ProSci operates in a competitive market with competitors including Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$600 K (USD), Grant
Jul 01, 2014
-
Investors
HHS
& 1 more
-
Employee Count
Not available
-
Acquired by
Genesee Scientific
(Feb 28, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ProSci
Investors in ProSci
ProSci has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Genesee Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Life science research products are sold via an online store.
|
Locked | Locked | Locked |
Investor details for ProSci
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ProSci
Investment portfolio details for ProSci
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ProSci
Detailed financials for ProSci
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prosci Comparisons
Peer comparison for ProSci
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ProSci
ProSci operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Technology for antibody-drug conjugation is provided by AbTis.
|
Detailed competitors of ProSci
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prosci
Complete news archive for ProSci
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ProSci
ProSci was founded in 1998 and raised its 1st funding round 10 years after it was founded.
ProSci is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
ProSci was founded in 1998 and is based in San Diego, United States, operating in the biotechnology sector. Custom antibodies, encompassing monoclonal, polyclonal, and single domain types, are developed for research applications. Primary antibodies, secondary antibodies, and recombinant antibodies are produced, alongside lysates and molecular biology reagents including antibody beads, loading control antibodies, detection sets, immunoblots, peptides, and cell slides. Operations focus on antibody-related products and tools.
ProSci's top competitors include Sino Biological, GenScript and Y-Biologics.
ProSci has 2 investors. Key investors include HHS, and Genesee Scientific.